| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥100.7B | ¥83.8B | +20.2% |
| Operating Income | ¥8.8B | ¥11.2B | -21.0% |
| Ordinary Income | ¥9.6B | ¥11.8B | -19.0% |
| Net Income | ¥8.9B | ¥7.4B | +20.3% |
| ROE | 12.9% | 11.0% | - |
FY2025 consolidated results: Revenue reached 100.7B yen (YoY +20.2%), while Operating Income declined to 8.8B yen (YoY -21.0%), Ordinary Income decreased to 9.6B yen (YoY -19.0%), and Net Income increased to 8.9B yen (YoY +20.3%). Despite robust top-line expansion of 16.9B yen, operating profit contracted by 2.3B yen due to increased SG&A expenses and higher unallocated corporate costs. Operating margin compressed approximately 450 basis points from 13.3% to 8.8%. The divergence between operating income decline and net income growth was primarily driven by gains on securities sales of 1.2B yen in non-operating income. Operating cash flow remained strong at 15.8B yen, representing 2.51x net income coverage, demonstrating robust cash conversion quality. The company forecasts significant profit recovery for the next fiscal year with operating income expected to reach 16.5B yen (+86.9%), which implies substantial margin improvement initiatives.
Revenue growth of +20.2% was driven primarily by the Value Cafeteria business segment, where Healthcare Support services expanded significantly from 4.8B yen to 6.2B yen (+28.6%), and Cafeteria services grew from 1.7B yen to 1.9B yen (+7.8%). The HR Management business also contributed with revenue increasing from 1.6B yen to 1.8B yen (+10.8%), led by health insurance association operations and related services expanding from 1.5B yen to 1.7B yen (+11.2%). This demonstrates broad-based growth across both reporting segments with Healthcare Support as the primary growth engine.
On the profit side, despite the 20% revenue expansion, operating income declined 21.0% from 11.2B yen to 8.8B yen. The primary driver was the increase in unallocated corporate costs, which expanded from 1.0B yen to 1.2B yen (+10.3% adjustment amount increase per segment notes). Additionally, SG&A expenses grew to 20.3B yen, representing 20.2% of revenue versus approximately 19.0% in the prior year, indicating operating leverage deterioration. Cost of sales increased proportionally with revenue growth from 59.8B yen to 71.5B yen, maintaining a relatively stable gross margin of 28.9%. Non-operating income provided partial offset through gains on securities sales of 1.2B yen, narrowing the gap between operating and ordinary income. The variance between ordinary income (9.6B yen, -19.0%) and net income (8.9B yen, +20.3%) exceeded 10%, explained by the prior year's extraordinary loss items including securities valuation losses and write-downs that did not recur in the current period, creating a favorable base effect for net income despite operational profit pressure.
This represents a revenue up/profit down pattern, where strong top-line momentum failed to translate into operating profit expansion due to cost structure pressures and increased corporate overhead allocation.
Value Cafeteria business generated revenue of 8.3B yen (+22.5% YoY) with segment operating profit of 1.7B yen (-10.1% YoY), resulting in a segment margin of 20.8% compared to 28.3% in the prior year. This segment represents the core business accounting for 82.0% of total consolidated revenue. The margin compression of 750 basis points reflects the impact of investment in service expansion and potential pricing pressures in the healthcare support domain despite strong volume growth.
HR Management business recorded revenue of 1.8B yen (+10.8% YoY) with segment operating profit of 321M yen (+26.3% YoY), achieving a segment margin of 17.7% compared to 15.6% in the prior year, representing a 210 basis point improvement. This segment accounts for 18.0% of consolidated revenue and demonstrates improving operational efficiency with profit growth outpacing revenue growth.
The material margin differential between segments (Value Cafeteria at 20.8% versus HR Management at 17.7%) reflects different business economics, though Value Cafeteria's declining margin trend warrants attention while HR Management shows positive momentum in profitability improvement. Unallocated corporate costs of 1.2B yen reduced consolidated operating margin by approximately 1,150 basis points, representing a significant overhead burden that management must address to restore overall profitability.
[Profitability] ROE of 12.9% represents reasonable return on equity but reflects the influence of financial leverage (2.64x) compensating for relatively modest net profit margin of 6.2%. Operating margin of 8.8% contracted 450 basis points year-over-year from approximately 13.3%, indicating significant profitability pressure. Gross margin remained stable at 28.9%, while SG&A ratio increased to 20.2% from approximately 19.0%, demonstrating operating deleverage. [Cash Quality] Cash and deposits stood at 49.3B yen, providing 0.77x coverage of current liabilities of 64.2B yen, indicating adequate but not abundant short-term liquidity. Operating cash flow of 15.8B yen represented 2.51x net income, confirming strong cash-backed earnings quality. Free cash flow of 8.7B yen demonstrates healthy cash generation capacity after capital expenditures of 2.4B yen. [Investment Efficiency] Total asset turnover of 0.55x reflects the service business model with relatively low asset intensity. Capital expenditure to depreciation ratio of 0.51x (2.4B yen CapEx versus 4.6B yen D&A) signals potential underinvestment in future growth capacity, falling short of the industry benchmark threshold of 0.7x. [Financial Health] Equity ratio of 37.9% provides moderate financial stability with total equity of 69.0B yen supporting total assets of 182.2B yen. Current ratio of 102.4% indicates limited liquidity cushion relative to the industry standard of 150%. Debt-to-equity ratio of 0.68x (interest-bearing debt of 46.7B yen) remains manageable, with interest coverage ratio of 14.71x demonstrating strong debt servicing capability. Debt-to-EBITDA of 3.46x approaches but remains below the 4.0x caution threshold.
Operating cash flow of 15.8B yen represents 2.51x net income of 6.3B yen, confirming strong cash conversion despite the decline in absolute operating cash flow of 21.9% year-over-year from 20.2B yen. The cash flow to EBITDA ratio of 1.17x demonstrates healthy earnings quality. Investing cash flow outflow of 7.1B yen was primarily driven by capital expenditures of 2.4B yen and net investments in securities. The CapEx to depreciation ratio of 0.51x indicates maintenance-level investment below full replacement requirements. Financing cash flow outflow of 12.2B yen primarily reflected debt repayments and dividend payments, with minimal share repurchases. Free cash flow of 8.7B yen (operating cash flow minus investing cash flow) provides 1.26x coverage of estimated dividend and CapEx requirements, confirming dividend sustainability in the current period. Cash and deposits increased from 47.6B yen to 49.3B yen (+1.7B yen) year-over-year, maintaining adequate liquidity despite cash distributions, though the current ratio of 102.4% indicates limited excess liquidity buffer. Working capital remained efficient with accounts receivable increasing 29.0% to 8.8B yen, proportional to revenue growth, though this warrants monitoring for potential collection cycle extension.
Ordinary income of 9.6B yen versus operating income of 8.8B yen shows non-operating net contribution of approximately 0.8B yen, primarily comprising gains on securities sales of 1.2B yen partially offset by valuation losses of 0.5B yen and interest expenses of 0.6B yen. Non-operating income represents approximately 1.2% of revenue, consisting mainly of investment gains that introduce earnings volatility and are non-recurring in nature. The compression between ordinary income (-19.0%) and operating income (-21.0%) indicates that investment gains partially masked operational profit deterioration. Operating cash flow of 15.8B yen substantially exceeds net income of 8.9B yen, indicating healthy earnings quality with minimal accrual manipulation concerns. The accruals ratio of -5.2% suggests earnings are well-supported by cash flows with no indication of aggressive accounting. The divergence between net income growth (+20.3%) and operating income decline (-21.0%) was driven by non-recurring factors: prior year extraordinary losses (securities valuation losses and special losses) created a favorable base effect, while current year gains on securities sales provided non-operating support, together masking the underlying operational profit pressure.
Progress rate versus full-year guidance shows revenue at 91.5% (100.7B yen actual versus 110.0B yen forecast), operating income at 53.5% (8.8B yen versus 16.5B yen forecast), and ordinary income at 58.8% (9.6B yen versus 16.3B yen forecast). The operating income progress rate of 53.5% significantly lags the standard 100% completion benchmark for full-year results, indicating the company expects substantial profit acceleration or is signaling conservative guidance. The forecast implies second-half or future period operating income must reach 7.7B yen to achieve the 16.5B yen full-year target, representing an 86.9% year-over-year improvement from the current year base. This projection assumes significant margin recovery through cost reduction initiatives, operating leverage improvement, or higher-value service mix shift. The operating margin implicit in guidance is 15.0% (16.5B yen / 110.0B yen), representing a 620 basis point recovery from current year's 8.8%, which constitutes an ambitious turnaround requirement. Forecast EPS of 39.31 yen versus actual EPS of 23.54 yen implies 67.0% earnings growth expectation. Key assumptions underlying the forecast include successful implementation of cost structure optimization, particularly in unallocated corporate expenses, and sustained revenue momentum with improved pricing or service mix. Investors should monitor quarterly progress on margin improvement initiatives and segment profitability trends to validate forecast achievability.
Annual dividend totaled 25.0 yen per share comprising interim dividend of 12.0 yen and year-end dividend of 13.0 yen. The dividend forecast for the next fiscal year is stated as 13.5 yen per share in the guidance data, though this appears to reference a per-period figure requiring clarification. Year-over-year dividend comparison shows the previous period structure maintained similar levels. Payout ratio calculation yields 108.9% when applied to current net income attributable to owners of parent of 6.3B yen against total dividend distribution, though the reported XBRL payout ratio of 0.8% creates significant discrepancy requiring reconciliation. The calculated payout ratio exceeding 100% raises sustainability concerns absent clarification on denominator definition. Free cash flow of 8.7B yen provides 1.26x coverage of estimated total shareholder distributions, indicating current dividend payments remain supportable by operating cash generation. No material share repurchase activity was recorded in the current period with buybacks of effectively 0.0B yen. The total return ratio remains equivalent to the payout ratio absent significant buybacks. Dividend sustainability depends on confirmation of the payout policy methodology and whether management intends to maintain absolute dividend levels or adjust to normalized earnings, particularly given the current year's operating profit pressure partially offset by non-recurring investment gains.
Operating margin compression risk: Operating margin declined 450 basis points from 13.3% to 8.8% driven by SG&A expense growth and unallocated corporate cost increases of 10.3%. The Value Cafeteria segment experienced 750 basis point margin erosion from 28.3% to 20.8%. Management's ability to execute cost structure optimization and achieve the forecasted margin recovery to 15.0% represents critical execution risk with potential further downside if initiatives fail to materialize.
Asset impairment risk on intangible investments: Intangible assets increased 39.1% to 10.8B yen (primarily software assets of 10.0B yen) and investment securities expanded 38.5% to 14.9B yen, together representing 14.1% of total assets. Software capitalization requires validation of recoverability through future cash flows, while investment securities experienced both gains (1.2B yen) and valuation losses (0.5B yen) indicating market sensitivity. Quantified exposure of 25.7B yen in combined intangible and investment assets warrants monitoring for potential write-down risk if business conditions deteriorate or technology investments fail to generate expected returns.
Liquidity and capital allocation pressure: Current ratio of 102.4% provides minimal short-term liquidity cushion below the industry benchmark of 150%, with current assets of 65.7B yen covering current liabilities of 64.2B yen by only 1.5B yen margin. The calculated dividend payout ratio of 108.9% combined with debt-to-EBITDA of 3.46x approaching the 4.0x threshold creates tension between shareholder returns, debt servicing, and investment requirements. Capital expenditure to depreciation ratio of 0.51x signals underinvestment potentially constraining future growth capacity. Free cash flow of 8.7B yen must balance competing demands for dividend maintenance (estimated 6.8B yen based on calculation), debt reduction to maintain financial flexibility, and increased CapEx to support growth, creating allocation pressure absent profit recovery.
[Industry Position] (Reference - Proprietary Analysis)
Value HR operates in the human resources services and healthcare benefit administration industry, providing welfare cafeteria systems and health insurance association operations outsourcing. Based on proprietary analysis, the company's financial metrics show mixed positioning relative to industry standards.
Profitability: ROE of 12.9% demonstrates reasonable equity returns supported by moderate financial leverage, though current operating margin of 8.8% reflects significant compression from prior year levels. The industry characteristics for HR services typically support operating margins in the 10-15% range for established platforms with scale, placing the company's current margin at the lower end requiring recovery to competitive positioning. The forecasted margin improvement to 15.0% would restore competitive parity.
Financial Health: Equity ratio of 37.9% provides moderate financial stability appropriate for a service business model with limited fixed asset requirements. The current ratio of 102.4% falls materially short of the typical industry liquidity benchmark of 150%, indicating constrained working capital flexibility compared to industry standards. Debt-to-EBITDA of 3.46x approaches but remains within acceptable leverage boundaries for the sector.
Efficiency: Operating margin of 8.8% has declined below typical industry standards of 10-15% for scaled HR services platforms, reflecting the cost structure pressures identified in the current year. Capital efficiency metrics including asset turnover of 0.55x align with service industry norms given low asset intensity, though the CapEx-to-depreciation ratio of 0.51x signals underinvestment relative to the 0.7x threshold for maintaining competitive service infrastructure and technology capabilities essential in the digitally-enabled HR services market.
Investment positioning relative to industry benchmarks suggests the company maintains adequate financial stability but requires operating margin restoration and enhanced investment in technology infrastructure to maintain competitive positioning within the evolving HR services landscape.
Revenue momentum remains robust with 20.2% growth demonstrating strong market demand for healthcare benefit administration and cafeteria welfare services, supported by secular tailwinds in outsourcing of health insurance operations and corporate welfare program management. The Healthcare Support sub-segment within Value Cafeteria business showed particularly strong 28.6% expansion, indicating successful penetration in core service offerings. Forward guidance of 9.3% revenue growth for next fiscal year suggests management expects sustained but moderating top-line momentum as the business scales from a larger revenue base of 100.7B yen.
Operating leverage deterioration represents the critical near-term challenge requiring resolution, evidenced by operating margin compression of 450 basis points to 8.8% despite 20% revenue growth. The ambitious forecast of 86.9% operating income recovery implies management has identified specific cost reduction initiatives and operational improvements, with implicit target margin of 15.0% requiring 620 basis point recovery. Validation of margin recovery execution through quarterly tracking of SG&A ratios, unallocated corporate cost trends, and segment-level profitability improvement, particularly in the Value Cafeteria segment where margins compressed 750 basis points, constitutes the primary determinant of earnings trajectory and valuation support.
Cash generation quality provides financial flexibility foundation with operating cash flow of 15.8B yen representing 2.51x net income coverage and free cash flow of 8.7B yen supporting capital allocation optionality. The tension between dividend sustainability (calculated payout ratio of 108.9% requiring clarification), underinvestment concerns (CapEx-to-depreciation of 0.51x), and leverage management (debt-to-EBITDA of 3.46x) creates capital allocation complexity requiring balanced resolution. The company's ability to restore operating profitability while maintaining adequate reinvestment in technology infrastructure and service capabilities, sustaining shareholder returns, and preserving financial flexibility represents the multi-dimensional management execution challenge observable from current earnings data.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.